💨 Abstract

On May 9, 2025, Ocugen, Inc. (OCGN) reported a first-quarter loss of $15.4 million, or 5 cents per share. The biotech company, based in Malvern, Pennsylvania, generated $1.5 million in revenue during the period.

Courtesy: wtop.com